He Who Pays the Piper

Abstract

The decision of the federal government in Australia not to accept the Pharmaceutical Benefits Advisory Committee's (PBAC) recommendation for new medicines and vaccines to be included in the Pharmaceutical Benefits Scheme (PBS) is discussed. The reasons for the controversial decision of the government are being debated.